comparemela.com

Latest Breaking News On - Swissmedic - Page 1 : comparemela.com

Orchard Therapeutics Gets Swissmedic Approval For Libmeldy In Early-onset MLD

Gene therapy leader Orchard Therapeutics plc (ORTX) announced Monday the Swiss Agency for Therapeutic Products (Swissmedic) has approved Libmeldy (atidarsagene autotemcel), a hematopoietic stem cell (HSC) gene therapy, for the treatment of early-onset metachromatic leukodystrophy (MLD).

Swiss agency for therapeutic products swissmedicOrchard therapeuticsSwiss agencyTherapeutic productsOrchard therapeuticsEne therapy leader orchard therapeuticsAtidarsagene autotemcel

Relief Therapeutics Holding SA: Relief Therapeutics Announces Swissmedic Approval and Operation of New Good Manufacturing Practice-Compliant Laboratory

Relief Therapeutics Holding SA / Key word(s): Regulatory Approval Relief Therapeutics Announces Swissmedic Approval and Operation of New Good Manufacturing Practice-Compliant Laboratory 15.05.2023

Switzerland generalJack weinsteinCatherine dayPaolo galfettiRelief therapeutics holdingInvestor relations communicationsNews serviceExchange commissionRelief therapeutics holding sa keySwiss agency for therapeutic products swissmedicCompliant laboratorySwiss exchangePharma researchRegulatory approvalTherapeutics announces swissmedic approvalTherapeutics announcesswissmedic approval

Idorsia Pharmaceuticals Ltd: Swissmedic approves QUVIVIQ (daridorexant) - a first-in-class treatment for chronic insomnia disorder to improve both nighttime symptoms and daytime functioning

QUVIVIQ is indicated for the treatment of adult patients with insomnia characterized by symptoms present for at least three months and considerable impact on daytime functioningQUVIVIQ, Switzerland's first

United statesUnited kingdomSwitzerland generalGreat britainAndrewc weissJean paul clozelAlice huismanJ clin pharmacolIdorsia ltdAmerican psychiatric associationHead of investor relations corporate communicationsEuropean commission decision reliance procedureEuropean commissionDrug administrationSwiss exchangeRegulatory agency

Swiss Drugs Regulator Looking Into Bubbles in COVID Booster Vials

BERLIN Swiss drugs regulator Swissmedic said on Wednesday it is examining potential risks in connection with bubbles that appeared .

United statesThe epoch times

Swissmedic Authorizes Novavax COVID-19 Vaccine For Adolescents And As Booster In Adults

WASHINGTON (dpa-AFX) - Novavax Inc. (NVAX) said that Swissmedic, the Swiss Agency for Therapeutic Products, has expanded its temporary authorization of Nuvaxovid (NVX-CoV2373) COVID-19 vaccine

United statesSwiss agency for therapeutic productsDrug administrationMore such health newsNovavax incSwiss agencyTherapeutic products

vimarsana © 2020. All Rights Reserved.